RO
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES | Journal of Controlled Release |  | 2019 | 268 | 694 | ||
| Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES | International Journal of Pharmaceutics |  | 2019 | 224 | 2 | ||
| Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration | Antimicrobial Agents and Chemotherapy | | 2017 | 452 | 1 | ||
| Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage | AIDS Research and Human Retroviruses | | 2017 | 397 | 0 | ||
| A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris | Protein expression and purification | | 2016 | 579 | 289 | ||
| Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention | Molecular pharmaceutics | | 2013 | 624 | 465 | ||
| CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity | Journal of virology |  | 2012 | 633 | 0 | ||
| Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use | PloS one | | 2011 | 724 | 310 | ||
| Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5 | Blood | | 2011 | 580 | 0 | ||
| "Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1SF162 or simian-human immunodeficiency virus SHIVSF162-p3 do not confer resistance | Journal of virology | | 2010 | 642 | 20 | ||
| Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge | The Journal of infectious diseases | | 2009 | 634 | 1 | ||
| Chemokine analogues show suitable stability for development as microbicides | Journal of acquired immune deficiency syndromes | | 2008 | 614 | 2 | ||
| Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 | Protein engineering, design & selection | | 2008 | 675 | 8 | ||
| Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein | Bioconjugate chemistry | | 2008 | 713 | 5 | ||
| Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide | Proceedings of the National Academy of Sciences of the United States of America | | 2008 | 618 | 2 | ||
| Microbicides and other topical strategies to prevent vaginal transmission of HIV | Nature reviews. Immunology | | 2006 | 605 | 0 | ||
| Engineering chemokines to develop optimized HIV inhibitors | Current protein and peptide science | 2005 | 584 | 0 | |||
| Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors | Proceedings of the National Academy of Sciences of the United States of America | | 2004 | 713 | 1 | ||
| PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes | Journal of virology | | 2004 | 676 | 0 | ||
| Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 | Science | | 2004 | 657 | 1 | ||
| Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES | Antimicrobial agents and chemotherapy | | 2003 | 662 | 61 | ||
| Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines | Journal of virology | | 2003 | 556 | 375 | ||
| Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression | Journal of virology | | 2001 | 635 | 1 | ||
| Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs | Journal of virology | | 2000 | 583 | 2 | ||
| Amino acid sequence determination by gas chromatography—mass spectrometry of permethylated peptides | Journal of chromatography | | 1983 | 719 | 0 | ||
| Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor | Biochemical journal | | 1979 | 636 | 0 | ||
| The degradation of semisynthetic tritiated insulin by perfused mouse livers | Biochemical journal | | 1976 | 587 | 0 |
